Aceto sells various pharmaceutical/nutritional ingredients
and other chemicals. Defendants
allegedly make and sell a line of prenatal vitamins, Prena1, that violate Aceto’s
exclusive US rights to a patented ingredient known as Quatrefolic and to the Quatrefolic
mark. Aceto entered into limited
sublicensing agreements for Quatrefolic, including one with Pernix. Pernix agreed to buy Quatrefolic exclusively
from Aceto, and had the right to sublicense further provided that Aceto
remained the direct supplier to the sublicensee (and retained other control
over the sublicense).
Defendants wanted to become sublicensees, and were allegedly
aware that Aceto had the right to review and approve all proposed sublicenses,
and that Aceto was required to be the direct supplier of Quatrefolic. Nonetheless, they allegedly obtained and sold
Quatrefolic products from Pernix without a license, and used the mark to
promote Prena1. Their website says “Prena1
with Quatrefolic®” is “The ONLY Authorized Generics Prescription Prenatals with
Quatrefolic® and life’s DHA™,” and contains an “unauthorized detailed
description” of Quatrefolic. (This seems
like a first sale issue, even from the plaintiff’s own allegations, though “authorized”
is a risky word to use.)
Defendants argued that Aceto failed to join required parties—Gnosis,
the licensor, and Pernix. The court
agreed about Gnosis and disagreed about Pernix.
A licensee’s standing to sue depends on its rights under the license. The court was in the dark about this because
the licensing agreement wasn’t attached to the complaint. The complaint did
allege exclusivity in the US, but didn’t allege that Gnosis assigned Aceto
ownership rights or that Aceto owned all substantial rights in the US, as
required for standing. Under the Lanham
Act, only the registrant of record has standing to sue under §32. “No amount of judicial interpretation or
manipulation of words can turn an exclusive licensee into an assignee. A
trademark assignment and license are two quite different transactions with
widely different impacts.” Likewise, as the Federal Circuit has held, “although
a patentee has standing to sue in its own name, an exclusive licensee that does
not have all substantial rights has standing to sue third parties only as a co-plaintiff
with the patentee.” Some cases suggest
that an exclusive licensee can sue if it has the right even to exclude the
licensor to the territory, but whether that was the case here was unclear; nor
was there evidence or allegations that Gnosis delegated to Aceto the obligation
to sue for trademark infringement. Plus, standing is related to but different
from joinder: defendants were arguing that Gnosis needed to be joined, and the
precedent supported that for exclusive patent licensees. “Thus, unless Plaintiff is an exclusive
licensee with all substantial rights in the trademark, all entities with an
independent right to enforce the Quatrefolic Mark are indispensable or
necessary parties to this infringement suit.”
Motion to dismiss for failure to join Gnosis granted, with leave to
amend. Gnosis could be made an
involuntary plaintiff (or defendant), or Aceto could demonstrate that it was an
assignee or the legal equivalent thereof.
Pernix, however, didn’t need to be joined, since it was just
a sublicensee. The court could determine
the parties’ rights without Pernix’s participation; all that was necessary was
reference to the Pernix-Aceto contract. Aceto could get the complete relief it sought
without it, and defendants hadn’t shown they were at risk of inconsistent
obligations from Pernix.
This got rid of the §43(a) claims and federal and state
dilution claims too. (Federal
dilution? Ugh, where is Rule 11 when you
need it?)
However, the claim for Florida common law unfair competition
survived. Aceto alleged false advertising
and other deceptive conduct, and that the parties acted as competitors with
respect to Prena1. Plus, the court
allowed a claim for violation of the
Florida Deceptive and Unfair Trade Practices Act to proceed. Though older case
law indicated that only consumers could sue under FDUTPA, its old language
allowing “a consumer who has suffered a loss as a result of a violation” to
bring a claim was changed from “consumer” to “person” in 2001. The statute’s stated purpose was “[t]o
protect the consuming public and legitimate business enterprises from those who
engage in unfair methods of competition, or unconscionable, deceptive, or
unfair acts or practices in the conduct of any trade or commerce.” The natural reading is that legitimate
business enterprises are a class sought to be protected by the statute.
An unjust enrichment claim, pleaded in the alternative, also
survived. The fact that Pernix was the one who directly conferred the benefit
on defendants didn’t matter; benefits conferred through an intermediary can
still amount to unjust enrichment.
No comments:
Post a Comment